Back to Search
Start Over
New Blood Coagulation Factors Findings from Daiichi Sankyo Pharma Development Outlined (A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects)
- Source :
- Obesity, Fitness & Wellness Week. June 24, 2017, 3347
- Publication Year :
- 2017
-
Abstract
- 2017 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Hematology - Blood Coagulation Factors have been presented. According [...]
- Subjects :
- Drug therapy
Research
Thrombin
Physical fitness
Stroke -- Drug therapy -- Research
Subjects
Details
- Language :
- English
- ISSN :
- 15316386
- Database :
- Gale General OneFile
- Journal :
- Obesity, Fitness & Wellness Week
- Publication Type :
- Periodical
- Accession number :
- edsgcl.495785559